Leap Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2011)

Organization Overview

First Clinical Trial
2011
NCT01239134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Leap Therapeutics | Leap Therapeutics, Inc.